Machine Learning Viz.ai Announces Expansion Into Outpatient Ambulatory Centers to Accelerate Clinical Trial… Business Wire Sep 28, 2023 Expansion brings AI-powered care coordination to underserved communities for clinical trial recruitment Viz.ai, the leader in AI-powered disease…
Machine Learning New Clinical Data Supports Viz.ai Solution for Improved Pulmonary Embolism Detection and Care… Business Wire Sep 22, 2023 Company’s Artificial Intelligence Technology Shows Better Results in Early Detection and Patient Care Viz.ai, the leader in AI-powered disease…
Machine Learning Viz.ai Receives First De Novo Approval by the FDA for Hypertrophic Cardiomyopathy AI Algorithm Business Wire Aug 16, 2023 New artificial intelligence algorithm for earlier detection and management of hypertrophic cardiomyopathy Viz.ai, the leader in AI-powered…
Machine Learning Viz.ai Appoints Hypertrophic Cardiomyopathy Medical Advisory Board to Advance Innovation Business Wire May 8, 2023 Leading experts to shape the future of Viz.ai’s HCM strategy and platform Viz.ai, the leader in AI-powered disease detection and intelligent care…
Machine Learning Viz.ai Named to Forbes AI 50 List of Top Artificial Intelligence Companies of 2023 Business Wire Apr 13, 2023 Only company in healthcare to be recognized for the fourth time Viz.ai, the leader in AI-powered disease detection and intelligent care…
Machine Learning Viz.ai Launches Viz Trauma Suite to Support Change in Trauma Center Standards Business Wire Mar 31, 2023 Tailored for trauma care providers to help expedite patient care and improve outcomes Viz.ai, the leader in AI-powered disease detection and…
Machine Learning CIBC Innovation Banking Provides $40 Million in Growth Capital Financing to Viz.ai Business Wire Mar 22, 2023 CIBC Innovation Banking announced that it has provided $40 million in growth capital financing to Viz.ai to expand the San Francisco-based company’s…
Machine Learning Viz.ai to Expedite Patient Enrollment in NIH-funded PE-TRACT Clinical Trial Business Wire Mar 6, 2023 Viz.ai’s AI-powered clinical research platform will be used to find, screen and enroll patients in a landmark study of catheter-directed therapy…
Machine Learning Viz.ai Announces Agreement with Bristol Myers Squibb to Enable Earlier Detection and Management of… Business Wire Mar 4, 2023 Viz.ai has submitted a de novo classification request to the FDA for a new AI algorithm intended to identify and triage patients suspected with…
Machine Learning Viz.ai Collaborates with Johns Hopkins to Expedite Patient Enrollment in Brain Injury Trial AIT News Desk Feb 14, 2023 Using Viz RECRUIT software, recruitment happens in real-time, around-the-clock, accelerating treatment development for patients with intracerebral…